Jacob Chacko, President and CEO at Oric Pharmaceuticals, Inc. (ORIC), bought 650,000 shares at $4.54 ($3.2M) on 2022-03-25, disclosed to the SEC on 2022-03-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.98 | 257,127 | $1.3M | 39.8% |
| 2 | $4.98 | 257,127 | $1.3M | 39.8% |
| 3 | $5.03 | 42,873 | $216K | 6.7% |
| 4 | $5.03 | 42,873 | $216K | 6.7% |
| 5 | $4.54 | 50,000 | $227K | 7.1% |
| Total | $4.95 avg | 650,000 |
| $3.2M |
| 100% |
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |